Email this article The treatment results of Ewing's sarcomas in children in Belarus Republic
- Authors: Kisialeu L.1, Aleinikova O.1
-
Affiliations:
- Republican Research Center for Pediatric Oncology, Hematology and Immunology, Minsk
- Issue: Vol 16, No 2 (2017)
- Pages: 26-32
- Section: Статьи
- Submitted: 10.08.2018
- Published: 10.06.2017
- URL: https://hemoncim.com/jour/article/view/51
- DOI: https://doi.org/10.24287/1726-1708-2017-16-2-26-32
- ID: 51
Cite item
Full Text
Abstract
Chemotherapy and local control are mandatory components of treatment for patients with Ewing's sarcoma (ES). The aim of the study where the survival rates and clinical and pathological characteristics of patients with ES in the Belarus Republic (RB) over a 15-year. Data of ES patients (n=108) obtained from the RB children's cancer-registry (included in the International Agency for Research on Cancer, IARC) were used in the work. Event-free survival was superior for localized EES compared with metastatic forms (64,5% vs 19,5%; р < 0.0001). Patient characteristics: sex, age, level of lactate dehydrogenase, tumor size and location were characterized by a wide range and did not allow distinguish groups of favorable or unfavorable outcome. Treatment results for RB patients with ES are similar to generally accepted standards. Patients with metastatic status need new treatment strategies. Also new approaches are needed for identification and curate for third of patients with localized ES forms and unfavorable outcomes.
Keywords
About the authors
L. Kisialeu
Republican Research Center for Pediatric Oncology, Hematology and Immunology, Minsk
Author for correspondence.
Email: leonslight@mail.ru
MD, PhD. Chief of Oncology and Hematology dept. for Older Children
223053 Minsk Region, Belarus, Frunzenskaya 43, v. Borovliany.
+375 172 654222
+375 (29) 663-78-33
Fax: +375 172 654222
O. Aleinikova
Republican Research Center for Pediatric Oncology, Hematology and Immunology, MinskBelarus
References
Supplementary files
